| 1 |
Sicchieri JMF, Gracia BMC, Pagano AP, Schiavoni IL, Navarro AM. Nutrition Assessment and Management of Late-Onset Tay-Sachs Disease: A Clinical Case Report. J Acad Nutr Diet 2022:S2212-2672(22)01255-2. [PMID: 36549564 DOI: 10.1016/j.jand.2022.12.006] [Reference Citation Analysis]
|
| 2 |
Alcántara C, Pérez M, Huedo P, Altadill T, Espadaler-mazo J, Arqués JL, Zúñiga M, Monedero V. Study of the biosynthesis and functionality of polyphosphate in Bifidobacterium longum KABP042.. [DOI: 10.21203/rs.3.rs-2230889/v1] [Reference Citation Analysis]
|
| 3 |
Maslennikov R, Efremova I, Ivashkin V, Zharkova M, Poluektova E, Shirokova E, Ivashkin K. Effect of probiotics on hemodynamic changes and complications associated with cirrhosis: A pilot randomized controlled trial. World J Hepatol 2022; 14(8): 1667-1677 [DOI: 10.4254/wjh.v14.i8.1667] [Reference Citation Analysis]
|
| 4 |
Gamal A, Elshaer M, Alabdely M, Kadry A, McCormick TS, Ghannoum M. The Mycobiome: Cancer Pathogenesis, Diagnosis, and Therapy. Cancers (Basel) 2022;14:2875. [PMID: 35740541 DOI: 10.3390/cancers14122875] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 5 |
Shruthi B, Deepa N, Somashekaraiah R, Adithi G, Divyashree S, Sreenivasa MY. Exploring biotechnological and functional characteristics of probiotic yeasts: A review. Biotechnol Rep (Amst) 2022;34:e00716. [PMID: 35257004 DOI: 10.1016/j.btre.2022.e00716] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 6 |
Lacotte P, Simons A, Bouttier S, Malet-villemagne J, Nicolas V, Janoir C. Inhibition of In Vitro Clostridioides difficile Biofilm Formation by the Probiotic Yeast Saccharomyces boulardii CNCM I-745 through Modification of the Extracellular Matrix Composition. Microorganisms 2022;10:1082. [DOI: 10.3390/microorganisms10061082] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 7 |
He C, Kong F, Chai X, Zou C, Zhu X, Zhao D, Tan LTH. Effect of Probiotic-Assisted Eradication of cagA+/vacA s1m1 Helicobacter pylori on Intestinal Flora. BioMed Research International 2022;2022:1-12. [DOI: 10.1155/2022/8607671] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 8 |
Vizcaino‐almeida CR, Guajardo‐flores D, Caroca‐cáceres R, Serna‐saldívar SO, Briones‐garcía M, Lazo‐vélez MA. Non‐conventional fermentation at laboratory scale of cocoa beans: Using probiotic microorganisms and substitution of mucilage by fruit pulps. Int J of Food Sci Tech 2022;57:4307-15. [DOI: 10.1111/ijfs.15757] [Reference Citation Analysis]
|
| 9 |
Abid R, Waseem H, Ali J, Ghazanfar S, Muhammad Ali G, Elasbali AM, Alharethi SH. Probiotic Yeast Saccharomyces: Back to Nature to Improve Human Health. JoF 2022;8:444. [DOI: 10.3390/jof8050444] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 10 |
Wang R, Sun J, Lassabliere B, Yu B, Liu SQ. Green tea fermentation with Saccharomyces boulardii CNCM I-745 and Lactiplantibacillus plantarum 299V. LWT 2022;157:113081. [DOI: 10.1016/j.lwt.2022.113081] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 11 |
Leal-Martínez F, Abarca-Bernal L, García-Pérez A, González-Tolosa D, Cruz-Cázares G, Montell-García M, Ibarra A. Effect of a Nutritional Support System to Increase Survival and Reduce Mortality in Patients with COVID-19 in Stage III and Comorbidities: A Blinded Randomized Controlled Clinical Trial. Int J Environ Res Public Health 2022;19:1172. [PMID: 35162195 DOI: 10.3390/ijerph19031172] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 12 |
Kushkevych I, Jampílek J. Effect of intestinal microbiome, antibiotics, and probiotics in the prevention and management of ulcerative colitis. Probiotics in the Prevention and Management of Human Diseases 2022. [DOI: 10.1016/b978-0-12-823733-5.00016-7] [Reference Citation Analysis]
|
| 13 |
Cui B, Lin L, Wang B, Liu W, Sun C. Therapeutic potential of Saccharomyces boulardii in liver diseases: from passive bystander to protective performer? Pharmacol Res 2021;175:106022. [PMID: 34883213 DOI: 10.1016/j.phrs.2021.106022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 14 |
Abiega-Franyutti P, Freyre-Fonseca V. Chronic consumption of food-additives lead to changes via microbiota gut-brain axis. Toxicology 2021;464:153001. [PMID: 34710536 DOI: 10.1016/j.tox.2021.153001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 15 |
Meng KL, Lv XC, Che HY, Li Y, Chen XL, Hu MX, Yan M. Joint protection strategies for Saccharomyces boulardii: exogenous encapsulation and endogenous biofilm structure. Appl Microbiol Biotechnol 2021;105:8469-79. [PMID: 34647135 DOI: 10.1007/s00253-021-11601-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 16 |
Kaźmierczak-Siedlecka K, Skonieczna-Żydecka K, Biliński J, Roviello G, Iannone LF, Atzeni A, Sobocki BK, Połom K. Gut Microbiome Modulation and Faecal Microbiota Transplantation Following Allogenic Hematopoietic Stem Cell Transplantation. Cancers (Basel) 2021;13:4665. [PMID: 34572894 DOI: 10.3390/cancers13184665] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 17 |
Singh A, Mandal UK, Narang RK. Development and characterization of enteric coated pectin pellets containing mesalamine and Saccharomyces boulardii for specific inflamed colon: In vitro and in vivo evaluation. Journal of Drug Delivery Science and Technology 2021;62:102393. [DOI: 10.1016/j.jddst.2021.102393] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 18 |
Mondal O, Khanna D, Panwar S, Negi S, Basu S. Systematic Review on Therapeutic Applications of Yeast 'Saccharomyces'. IJSRST. [DOI: 10.32628/ijsrst218226] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 19 |
Kaźmierczak-Siedlecka K, Dvořák A, Folwarski M, Daca A, Przewłócka K, Makarewicz W. Fungal Gut Microbiota Dysbiosis and Its Role in Colorectal, Oral, and Pancreatic Carcinogenesis. Cancers (Basel) 2020;12:E1326. [PMID: 32455985 DOI: 10.3390/cancers12051326] [Cited by in Crossref: 24] [Cited by in F6Publishing: 29] [Article Influence: 8.0] [Reference Citation Analysis]
|
